Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients.
Kashiwado Y, Kimoto Y, Ohshima S, Sawabe T, Irino K, Nakano S, Hiura J, Yonekawa A, Wang Q, Doi G, Ayano M, Mitoma H, Ono N, Arinobu Y, Niiro H, Hotta T, Kang D, Shimono N, Akashi K, Takeuchi T, Horiuchi T.
Kashiwado Y, et al. Among authors: irino k.
Rheumatology (Oxford). 2024 Mar 1;63(3):725-733. doi: 10.1093/rheumatology/kead275.
Rheumatology (Oxford). 2024.
PMID: 37289506